Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO and HAIFA, Israel, Feb. 19, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is proud to announce its inclusion in the 2025...
-
NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
-
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
-
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
-
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
-
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million